AB2 BIO RECEIVES $30 MILLION FROM NIPPON SHINYAKU FOR EXCLUSIVE U.S. COMMERCIALIZATION RIGHTS TO TADEKINIG ALFA

Reuters · 2d ago

Please log in to view news